Wung Jeon - Seoulin Bioscience Non-Executive Independent Director
| 038070 Stock | KRW 7,340 230.00 3.23% |
Director
Jeon Wung was NonExecutive Independent Director of Seoulin Bioscience Co., Ltd. since March 25, 2011. Jeon used to be Chief Executive Officer, President and Vice President of NH INVESTMENTSECURITIES CO., LTD, Vice Chairman of Mille21 Co., Ltd and Director of KYOBO Investment Trust Management Co., Ltd. since 2011.
| Age | 60 |
| Tenure | 14 years |
| Phone | (82) 31 628 3007 |
| Web | www.seoulin.co.kr |
Seoulin Bioscience Management Efficiency
The company has return on total asset (ROA) of 0.0554 % which means that it generated a profit of $0.0554 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 10.8133 %, meaning that it generated $10.8133 on every $100 dollars invested by stockholders. Seoulin Bioscience's management efficiency ratios could be used to measure how well Seoulin Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | DIRECTOR Age | ||
| Gang Choi | UNISEM Co | 47 | |
| Sang Son | UNISEM Co | 49 | |
| Guk Oh | UNISEM Co | 57 | |
| Eun Jung | UNISEM Co | 58 | |
Management Performance
| Return On Equity | 10.81 | |||
| Return On Asset | 0.0554 |
Seoulin Bioscience CoLtd Leadership Team
Elected by the shareholders, the Seoulin Bioscience's board of directors comprises two types of representatives: Seoulin Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Seoulin. The board's role is to monitor Seoulin Bioscience's management team and ensure that shareholders' interests are well served. Seoulin Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Seoulin Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mi Kang, Assistant Managing Director | ||
| Jae Oh, Internal Auditor | ||
| NaeDong Kim, Director Director | ||
| Eul Hwang, Chief Executive Officer, Director | ||
| Wung Jeon, Non-Executive Independent Director | ||
| KulYong Choi, Director Director | ||
| Gi Choi, Managing Director | ||
| Geol Choi, Managing Director | ||
| Gil SiYang, Chief Director | ||
| IkYoung Kim, Advising Director | ||
| Jong Ahn, Managing Director |
Seoulin Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Seoulin Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 10.81 | |||
| Return On Asset | 0.0554 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 165.44 B | |||
| Shares Outstanding | 7.3 M | |||
| Shares Owned By Insiders | 31.19 % | |||
| Shares Owned By Institutions | 1.55 % | |||
| Price To Earning | 42.30 X | |||
| Price To Sales | 1.05 X |
Pair Trading with Seoulin Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Seoulin Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seoulin Bioscience will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Seoulin Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Seoulin Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Seoulin Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Seoulin Bioscience CoLtd to buy it.
The correlation of Seoulin Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Seoulin Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Seoulin Bioscience CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Seoulin Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Seoulin Stock
Seoulin Bioscience financial ratios help investors to determine whether Seoulin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seoulin with respect to the benefits of owning Seoulin Bioscience security.